» Articles » PMID: 20010791

Oxygen-induced Retinopathy: a Model for Vascular Pathology in the Retina

Overview
Journal Eye (Lond)
Specialty Ophthalmology
Date 2009 Dec 17
PMID 20010791
Citations 102
Authors
Affiliations
Soon will be listed here.
Abstract

Ischaemic vascular disease in the retina may either leave retina permanently ischaemic with slow degradation of vision, or alternatively lead to proliferative vascular disease, which can also destroy vision. To investigate the molecular and cellular mechanisms that contribute to this pathology a mouse model has been studied extensively. The model is based on the exposure of mouse pups to hyperoxia during a phase when their retinal vasculature is still developing. This leads to capillary depletion, and upon return to room air, results in retinal ischaemia and proliferative vascular disease in the retinal vasculature (oxygen-induced retinopathy (OIR)). Numerous studies using this OIR model have revealed that the regulation of angiogenic factors and the influence of inflammatory cells play a pivotal role in the vascular pathogenesis. It has also been demonstrated in the OIR model that proliferative vascular disease is not the only possible outcome of ischaemia-induced angiogenesis in the retina, but that ischaemic areas in the retina can be revascularised with healthy blood vessels. Therefore, understanding the factors that control the balance between pathological and healthy angiogenesis in the OIR model may have important implications for human retinal ischaemic disease.

Citing Articles

Ref-1 redox activity regulates retinal neovascularization by modulating transcriptional activation of HIF-1α.

Hartman G, Muniyandi A, Sishtla K, Kpenu E, Miller W, Kaplan B FASEB J. 2025; 39(3):e70348.

PMID: 39902892 PMC: 11792779. DOI: 10.1096/fj.202401989RR.


mTOR downregulation promotes anti-inflammatory responses via the CCL3-CCR5 axis in hypoxic retinopathy.

Moon T, Kang I, Lee K, Kim J, Kim H, Han A Mol Ther Methods Clin Dev. 2025; 33(1):101404.

PMID: 39897639 PMC: 11787640. DOI: 10.1016/j.omtm.2024.101404.


The therapeutic potential of targeting Oncostatin M and the interleukin-6 family in retinal diseases: A comprehensive review.

Mori T, Nagaraj N, Surico P, Zhou W, Parmar U, DEsposito F Open Life Sci. 2025; 19(1):20221023.

PMID: 39759107 PMC: 11699559. DOI: 10.1515/biol-2022-1023.


Development of an Open-Source Dataset of Flat-Mounted Images for the Murine Oxygen-Induced Retinopathy Model of Ischemic Retinopathy.

Marra K, Chen J, Robles-Holmes H, Ly K, Miller J, Wei G Transl Vis Sci Technol. 2024; 13(12):4.

PMID: 39625436 PMC: 11620014. DOI: 10.1167/tvst.13.12.4.


Addressing retinal hypoxia: pathophysiology, therapeutic innovations, and future prospects.

Gnanasambandam B, Prince J, Limaye S, Moran E, Lee B, Huynh J Ther Adv Ophthalmol. 2024; 16:25158414241280187.

PMID: 39376745 PMC: 11457288. DOI: 10.1177/25158414241280187.